Literature DB >> 26296565

Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury.

Sioui Maldonado-Bouchard1, Kelsey Peters2, Sarah A Woller3, Behrouz Madahian4, Usef Faghihi5, Shivani Patel2, Shameena Bake6, Michelle A Hook6.   

Abstract

Spinal cord injury (SCI) leads to increased anxiety and depression in as many as 60% of patients. Yet, despite extensive clinical research focused on understanding the variables influencing psychological well-being following SCI, risk factors that decrease it remain unclear. We hypothesized that excitation of the immune system, inherent to SCI, may contribute to the decrease in psychological well-being. To test this hypothesis, we used a battery of established behavioral tests to assess depression and anxiety in spinally contused rats. The behavioral tests, and subsequent statistical analyses, revealed three cohorts of subjects that displayed behavioral characteristics of (1) depression, (2) depression and anxiety, or (3) no signs of decreased psychological well-being. Subsequent molecular analyses demonstrated that the psychological cohorts differed not only in behavioral symptoms, but also in peripheral (serum) and central (hippocampi and spinal cord) levels of pro-inflammatory cytokines. Subjects exhibiting a purely depression-like profile showed higher levels of pro-inflammatory cytokines peripherally, whereas subjects exhibiting a depression- and anxiety-like profile showed higher levels of pro-inflammatory cytokines centrally (hippocampi and spinal cord). These changes in inflammation were not associated with injury severity; suggesting that the association between inflammation and the expression of behaviors characteristic of decreased psychological well-being was not confounded by differential impairments in motor ability. These data support the hypothesis that inflammatory changes are associated with decreased psychological well-being following SCI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Inflammation; Spinal cord injury

Mesh:

Substances:

Year:  2015        PMID: 26296565      PMCID: PMC4679693          DOI: 10.1016/j.bbi.2015.08.009

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  106 in total

Review 1.  Neural plasticity to stress and antidepressant treatment.

Authors:  R S Duman; J Malberg; J Thome
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

2.  Causes of death after spinal cord injury.

Authors:  R J Soden; J Walsh; J W Middleton; M L Craven; S B Rutkowski; J D Yeo
Journal:  Spinal Cord       Date:  2000-10       Impact factor: 2.772

3.  Evaluating self-reported pressure ulcer prevention measures in persons with spinal cord injury using the revised Skin Management Needs Assessment Checklist: reliability study.

Authors:  A Gélis; J P Daures; C Benaim; P Kennedy; T Albert; D Colin; P-A Joseph; J Pelissier; C Fattal
Journal:  Spinal Cord       Date:  2011-01-11       Impact factor: 2.772

4.  A sensitive and reliable locomotor rating scale for open field testing in rats.

Authors:  D M Basso; M S Beattie; J C Bresnahan
Journal:  J Neurotrauma       Date:  1995-02       Impact factor: 5.269

Review 5.  A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities.

Authors:  Thaddeus W W Pace; Christine M Heim
Journal:  Brain Behav Immun       Date:  2010-10-08       Impact factor: 7.217

6.  Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype.

Authors:  J Müller-Berghaus; K Kern; A Paschen; X D Nguyen; H Klüter; G Morahan; D Schadendorf
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

Review 7.  The role of MIP-1 alpha in inflammation and hematopoiesis.

Authors:  D N Cook
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

8.  Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion.

Authors:  Jonathan Z Pan; Li Ni; Ajeet Sodhi; Ann Aguanno; Wise Young; Ronald P Hart
Journal:  J Neurosci Res       Date:  2002-05-01       Impact factor: 4.164

9.  The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.

Authors:  A Kapp; G Zeck-Kapp; W Czech; E Schöpf
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

10.  Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.

Authors:  Andrew Menzies-Gow; Sun Ying; Ian Sabroe; Victoria L Stubbs; Dulce Soler; Timothy J Williams; A Barry Kay
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  26 in total

Review 1.  Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives.

Authors:  Rani Shiao; Corinne A Lee-Kubli
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

2.  Systemic Inhibition of Soluble Tumor Necrosis Factor with XPro1595 Exacerbates a Post-Spinal Cord Injury Depressive Phenotype in Female Rats.

Authors:  Kaitlin Farrell; John D Houle
Journal:  J Neurotrauma       Date:  2019-07-10       Impact factor: 5.269

3.  Endoplasmic Reticulum Stress and Disrupted Neurogenesis in the Brain Are Associated with Cognitive Impairment and Depressive-Like Behavior after Spinal Cord Injury.

Authors:  Junfang Wu; Zaorui Zhao; Alok Kumar; Marta M Lipinski; David J Loane; Bogdan A Stoica; Alan I Faden
Journal:  J Neurotrauma       Date:  2016-05-16       Impact factor: 5.269

4.  High serum levels of malondialdehyde and antioxidant enzymes are associated with post-stroke anxiety.

Authors:  Zhihua Liu; Yan Cai; Xingru Zhang; Zhuoying Zhu; Jincai He
Journal:  Neurol Sci       Date:  2018-03-06       Impact factor: 3.307

5.  Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depression.

Authors:  Edem Ekpenyong Edem; Collins-Kevin Chukwudi Anyanwu; Kate Eberechukwu Nebo; Elizabeth Toyin Akinluyi; Adedamola Adediran Fafure; Azeez Olakunle Ishola; Linus Anderson Enye
Journal:  Psychopharmacology (Berl)       Date:  2021-11-18       Impact factor: 4.530

Review 6.  Behavioral testing in animal models of spinal cord injury.

Authors:  K Fouad; C Ng; D M Basso
Journal:  Exp Neurol       Date:  2020-07-28       Impact factor: 5.330

7.  Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice.

Authors:  Tianyao Liu; Yuanyuan Ma; Ruiyu Zhang; Hongyu Zhong; Lian Wang; Jinghui Zhao; Ling Yang; Xiaotang Fan
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

8.  Spinal cord injury alters microRNA and CD81+ exosome levels in plasma extracellular nanoparticles with neuroinflammatory potential.

Authors:  Niaz Z Khan; Tuoxin Cao; Junyun He; Rodney M Ritzel; Yun Li; Rebecca J Henry; Courtney Colson; Bogdan A Stoica; Alan I Faden; Junfang Wu
Journal:  Brain Behav Immun       Date:  2020-12-09       Impact factor: 7.217

9.  Sexual dimorphism in neurological function after SCI is associated with disrupted neuroinflammation in both injured spinal cord and brain.

Authors:  Yun Li; Rodney M Ritzel; Zhuofan Lei; Tuoxin Cao; Junyun He; Alan I Faden; Junfang Wu
Journal:  Brain Behav Immun       Date:  2021-12-23       Impact factor: 7.217

10.  Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota.

Authors:  Emma K A Schmidt; Pamela J F Raposo; Abel Torres-Espin; Keith K Fenrich; Karim Fouad
Journal:  J Neuroinflammation       Date:  2021-06-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.